Bio-Techne Corp at Stephens Investor Conference Transcript
All right. We'll go through my introduction, again. I'm Jacob Johnson, one of the healthcare analysts here at Stephens. Next up, joining us is Bio-Techne, a diversified life science tools company with a portfolio that includes reagents, instruments and services for research and clinical diagnostic markets worldwide. Joining us today are CFO, Jim Hippel; and Senior Director of IR and Corporate Development, Dave Clair. Thank you, guys, for joining us. Maybe to kick things off, Jim or Dave, if you just want to spend a couple of minutes running through the Bio-Techne story, and then we'll launch into Q&A.
Sure. I'll try to -- I'll do just it relatively briefly. Several in the room here, who I spoke to, know our story already. But our core is that we are a 40-year-old plus business that was one of the first companies, if not the first companies, to manufacture proteins for life science research. And in doing so over the last 40
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
